Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase

Imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase

US Patent 11325905 · Granted May 10, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intranasal compositions for treatment of neurological and neurodegenerative dise2024
Pyrrolotriazine compounds and methods of inhibiting TAM kinases2021
Intranasal compositions for treatment of neurological and neurodegenerative dise2021
Intranasal compositions for treatment of neurological and neurodegenerative dise2019
Synthetic lethality in cancer2018
Synthetic lethality in cancer2018
Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose)2017
Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose)2017
Boronic acid catalysts and methods of use thereof for activation and transformat2016
Poly(ethylene oxide)-block-poly(ester) block copolymers2015
Synthetic lethality in cancer2015
Synthetic lethality in cancer2015